Trial Outcomes & Findings for Laparoscopic Narrow Band Imaging for Detection of Occult Cancer Metastases (NCT NCT01944930)

NCT ID: NCT01944930

Last Updated: 2021-01-08

Results Overview

number of additionally visualized peritoneal lesions

Recruitment status

COMPLETED

Study phase

PHASE1

Target enrollment

23 participants

Primary outcome timeframe

After each Laparoscopy, at time of procedure

Results posted on

2021-01-08

Participant Flow

Participant milestones

Participant milestones
Measure
Narrow Band Imaging Laparoscopy First
Study has single cohort assessed in crossover design. In this arm NBI laparoscopy will be performed first, followed by standard white-light laparoscopy. Laparoscopic narrow band imaging Standard white-light laparoscopy
Standard White-Light Laparoscopy First
Study has single cohort assessed in crossover design. In this arm standard white-light laparoscopy will be performed first, followed by NBI laparoscopy. Laparoscopic narrow band imaging Standard white-light laparoscopy
Overall Study
STARTED
12
11
Overall Study
COMPLETED
10
10
Overall Study
NOT COMPLETED
2
1

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Laparoscopic Narrow Band Imaging for Detection of Occult Cancer Metastases

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Narrow Band Imaging Laparoscopy First
n=10 Participants
Study has single cohort assessed in crossover design. In this arm NBI laparoscopy will be performed first, followed by standard white-light laparoscopy. Laparoscopic narrow band imaging Standard white-light laparoscopy
Standard White-Light Laparoscopy First
n=10 Participants
Study has single cohort assessed in crossover design. In this arm standard white-light laparoscopy will be performed first, followed by NBI laparoscopy. Laparoscopic narrow band imaging Standard white-light laparoscopy
Total
n=20 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
10 Participants
n=5 Participants
10 Participants
n=7 Participants
20 Participants
n=5 Participants
Age, Categorical
>=65 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Age, Continuous
70 years
STANDARD_DEVIATION 9 • n=5 Participants
56 years
STANDARD_DEVIATION 13 • n=7 Participants
63 years
STANDARD_DEVIATION 13 • n=5 Participants
Sex: Female, Male
Female
5 Participants
n=5 Participants
4 Participants
n=7 Participants
9 Participants
n=5 Participants
Sex: Female, Male
Male
5 Participants
n=5 Participants
6 Participants
n=7 Participants
11 Participants
n=5 Participants
Region of Enrollment
United States
10 participants
n=5 Participants
10 participants
n=7 Participants
20 participants
n=5 Participants

PRIMARY outcome

Timeframe: After each Laparoscopy, at time of procedure

number of additionally visualized peritoneal lesions

Outcome measures

Outcome measures
Measure
Narrow Band Imaging Laparoscopy
n=20 Participants
Study has single cohort assessed in crossover design. In this arm NBI laparoscopy will be performed first, followed by standard white-light laparoscopy. Laparoscopic narrow band imaging
Standard White-Light Laparoscopy
n=20 Participants
Study has single cohort assessed in crossover design. In this arm standard white-light laparoscopy will be performed first, followed by NBI laparoscopy. Standard white-light laparoscopy
Rate of Detectable Peritoneal Metastases
0 percentage of lesions
2 percentage of lesions

Adverse Events

Narrow Band Imaging Laparoscopy First

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Standard White-Light Laparoscopy First

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Thomas Schnelldorfer

Lahey Hospital and Medical Center

Phone: 781-744-5100

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place